Scarica l'app Stockscreener
1.94
1.57%
0.03
Dopo l'orario di chiusura:
1.91
-0.03
-1.55%
Precedente Chiudi:
$1.91
Aprire:
$1.93
Volume 24 ore:
1.06M
Relative Volume:
0.84
Capitalizzazione di mercato:
$122.62M
Reddito:
$139.77M
Utile/perdita netta:
$-97.62M
Rapporto P/E:
-1.2278
EPS:
-1.58
Flusso di cassa netto:
$-61.71M
1 W Prestazione:
+14.12%
1M Prestazione:
+18.29%
6M Prestazione:
-16.38%
1 anno Prestazione:
-41.57%
Intervallo 1D:
$1.84
$2.04
Intervallo di 1 settimana:
$1.7107
$2.04
Portata 52W:
$0.9897
$5.10
Macrogenics Inc Stock (MGNX) Company Profile
Nome
Macrogenics Inc
Settore
Industria
Telefono
301-251-5172
Indirizzo
9704 MEDICAL CENTER DRIVE, Rockville, MD
Confronta MGNX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MGNX
Macrogenics Inc
|
1.94 | 109.98M | 139.77M | -97.62M | -61.71M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Macrogenics Inc Stock (MGNX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-07 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-01 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-07-31 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2024-07-31 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-05-10 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-05-10 | Downgrade | Stifel | Buy → Hold |
| 2024-05-10 | Downgrade | TD Cowen | Buy → Hold |
| 2024-04-26 | Iniziato | B. Riley Securities | Buy |
| 2024-04-09 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-03-04 | Reiterato | BTIG Research | Buy |
| 2024-02-14 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-12-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-11-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2023-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-11-22 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-11-14 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2022-07-18 | Downgrade | SMBC Nikko | Outperform → Neutral |
| 2022-07-11 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2022-05-04 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-02-28 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-02-11 | Iniziato | BMO Capital Markets | Outperform |
| 2022-02-04 | Iniziato | SMBC Nikko | Outperform |
| 2021-11-17 | Ripresa | Guggenheim | Buy |
| 2021-10-19 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-03-12 | Aggiornamento | Barclays | Underweight → Overweight |
| 2020-12-22 | Ripresa | H.C. Wainwright | Buy |
| 2020-08-03 | Downgrade | Citigroup | Buy → Neutral |
| 2020-06-01 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-05-26 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-04 | Iniziato | Barclays | Underweight |
| 2019-12-19 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-12-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-11-21 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2019-11-20 | Ripresa | Guggenheim | Neutral |
| 2019-05-03 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2019-04-12 | Iniziato | Guggenheim | Neutral |
| 2019-02-07 | Aggiornamento | Citigroup | Sell → Buy |
| 2019-02-07 | Downgrade | Wedbush | Outperform → Neutral |
| 2019-02-06 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
| 2019-02-04 | Downgrade | Citigroup | Neutral → Sell |
| 2018-12-10 | Downgrade | Raymond James | Outperform → Underperform |
| 2018-09-10 | Ripresa | BTIG Research | Buy |
| 2018-05-31 | Iniziato | Evercore ISI | Outperform |
| 2018-03-05 | Iniziato | H.C. Wainwright | Buy |
| 2017-03-31 | Iniziato | Raymond James | Outperform |
Mostra tutto
Macrogenics Inc Borsa (MGNX) Ultime notizie
Can MacroGenics Inc. stock double in the next yearJuly 2025 EndofMonth & Momentum Based Trading Ideas - khodrobank.com
News impact scoring models applied to MacroGenics Inc.Weekly Trend Recap & Low Risk Entry Point Guides - Newser
How to build a dashboard for MacroGenics Inc. stockGap Up & Stepwise Entry and Exit Trade Signals - Newser
Can MacroGenics Inc. reach all time highs this yearWeekly Trade Analysis & Smart Investment Allocation Insights - khodrobank.com
Strategies to average down on MacroGenics Inc.Weekly Trade Review & Detailed Earnings Play Alerts - Newser
Will MacroGenics Inc. benefit from macro trendsTrade Risk Assessment & Daily Volume Surge Signals - Newser
What to do if you’re stuck in MacroGenics Inc.Rate Hike & AI Driven Stock Reports - Newser
How to interpret RSI for MacroGenics Inc. stockInflation Watch & Risk Controlled Stock Pick Alerts - Newser
Can MacroGenics Inc. recover in the next quarterMarket Activity Recap & Community Verified Watchlist Alerts - Newser
Trend analysis for MacroGenics Inc. this week2025 Performance Recap & Verified Trade Idea Suggestions - Newser
Measuring MacroGenics Inc.’s beta against major indicesJuly 2025 Highlights & Daily Stock Trend Watchlist - Newser
Pattern recognition hints at MacroGenics Inc. upsideBear Alert & Expert Curated Trade Setups - Newser
Trend Report: Can MacroGenics Inc. stock double in the next yearTrade Entry Summary & High Return Trade Guides - khodrobank.com
MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
How liquid is MacroGenics Inc. stockJuly 2025 Movers & AI Powered Trade Plan Recommendations - khodrobank.com
Institutional scanner results for MacroGenics Inc.2025 Fundamental Recap & Verified Short-Term Plans - Newser
What is MacroGenics Inc. s 5 year growth outlookQuarterly Market Summary & Expert Approved Momentum Trade Ideas - khodrobank.com
How to track smart money flows in MacroGenics Inc.Weekly Earnings Recap & Low Volatility Stock Suggestions - Newser
Smart tools for monitoring MacroGenics Inc.’s price action2025 Earnings Surprises & AI Powered Buy and Sell Recommendations - Newser
Is MacroGenics Inc. stock heavily shortedJuly 2025 PreEarnings & Technical Entry and Exit Tips - khodrobank.com
Applying Elliott Wave Theory to MacroGenics Inc.2025 Technical Overview & Technical Pattern Alert System - Newser
Key metrics from MacroGenics Inc.’s quarterly data2025 Sector Review & Technical Confirmation Trade Alerts - Newser
Using fundamentals and technicals on MacroGenics Inc.2025 Top Gainers & Capital Efficient Trade Techniques - Newser
Is MacroGenics Inc. exposed to political riskFed Meeting & Verified Momentum Stock Watchlist - khodrobank.com
Will MacroGenics Inc. benefit from AI trends2025 Buyback Activity & Expert Curated Trade Setups - khodrobank.com
Technical Charts Suggest Momentum Shift in MacroGenics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Long term hold vs stop loss in MacroGenics Inc.2025 Pullback Review & AI Powered Market Trend Analysis - Newser
Can MacroGenics Inc. Rally Enough to Break Even getLinesFromResByArray error: size == 0 - 클래시안
Chart based exit strategy for MacroGenics Inc.Quarterly Growth Report & Safe Investment Capital Preservation Plans - Newser
Published on: 2025-08-31 08:28:48 - Newser
How to build a custom watchlist for MacroGenics Inc.Earnings Recap Summary & Consistent Return Investment Signals - Newser
Analyzing net buyer seller activity in MacroGenics Inc.Trade Risk Report & Low Risk High Reward Ideas - Newser
Is MacroGenics Inc. stock reversal real or fakeJuly 2025 Outlook & Short-Term Trading Alerts - Newser
Published on: 2025-08-30 21:45:29 - Newser
MacroGenics Inc. Included in Top Momentum ScanJuly 2025 Price Swings & Low Risk High Win Rate Stock Picks - beatles.ru
Is MacroGenics Inc. forming a bottoming base2025 Major Catalysts & Free Growth Oriented Trading Recommendations - Newser
Macrogenics Inc Azioni (MGNX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Macrogenics Inc Azioni (MGNX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| HEIDEN WILLIAM K | Director |
Aug 20 '25 |
Buy |
1.49 |
49,500 |
73,755 |
111,000 |
| Koenig Scott | Director |
Aug 13 '25 |
Option Exercise |
0.00 |
52,829 |
0 |
830,244 |
| Bonvini Ezio | Sr VP, Research & CSO |
Feb 15 '25 |
Option Exercise |
0.00 |
16,665 |
0 |
124,414 |
| Karrels James | SVP, CFO and Secretary |
Feb 15 '25 |
Option Exercise |
0.00 |
14,998 |
0 |
192,591 |
| Koenig Scott | President and CEO |
Feb 15 '25 |
Option Exercise |
0.00 |
42,329 |
0 |
777,415 |
| Peters Jeffrey Stuart | Senior VP and General Counsel |
Feb 15 '25 |
Option Exercise |
0.00 |
13,332 |
0 |
18,858 |
| Risser Eric Blasius | Chief Operating Officer |
Feb 15 '25 |
Option Exercise |
0.00 |
16,665 |
0 |
62,422 |
| Smith Beth Ann | VP, Controller & Treasurer |
Feb 15 '25 |
Option Exercise |
0.00 |
1,095 |
0 |
9,955 |
| Smith Beth Ann | VP, Controller & Treasurer |
Feb 15 '25 |
Sale |
2.56 |
423 |
1,083 |
9,532 |
| Spitznagel Thomas | Sr VP, Technical Ops |
Feb 15 '25 |
Option Exercise |
0.00 |
13,332 |
0 |
26,922 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):